RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+0.65%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$1.97B
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
93
Increased
1,360
Reduced
1,565
Closed
46
Top Buys
| 1 |
Moderna
MRNA
|
+$63.3M |
| 2 |
Analog Devices
ADI
|
+$46M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$36.7M |
| 4 |
Match Group
MTCH
|
+$29M |
| 5 |
Tesla
TSLA
|
+$20.3M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$86.6M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$77.4M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$76.7M |
| 4 |
Apple
AAPL
|
+$74M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$67.8M |
Sector Composition
| 1 | Technology | 23.92% |
| 2 | Financials | 14.19% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Babcock & Wilcox
BW
$203M
| $376K | ﹤0.01% |
58,664
+2,062
| +4% | +$13.2K |
|
2677
Taysha Gene Therapies
TSHA
$895M
| $375K | ﹤0.01% |
20,131
+1,460
| +8% | +$27.2K |
|
2678
Erasca
ERAS
$440M
| $374K | ﹤0.01% |
+17,642
| New | +$374K |
|
2679
PureCycle Technologies
PCT
$2.41B
| $374K | ﹤0.01% |
28,154
+1,550
| +6% | +$20.6K |
|
2680
United States Lime & Minerals
USLM
$3.51B
| $370K | ﹤0.01% |
15,310
+485
| +3% | +$11.7K |
|
|
ARD
2681
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $370K | ﹤0.01% |
14,503
-1,354
| -9% | -$34.5K |
|
2682
MediaAlpha
MAX
$707M
| $367K | ﹤0.01% |
19,639
+1,180
| +6% | +$22.1K |
|
2683
Quantum Corp
QMCO
$106M
| $367K | ﹤0.01% |
3,547
+96
| +3% | +$9.93K |
|
2684
VirnetX
VHC
$82.3M
| $366K | ﹤0.01% |
4,665
+56
| +1% | +$4.39K |
|
2685
Lifecore Biomedical
LFCR
$273M
| $365K | ﹤0.01% |
39,589
+756
| +2% | +$6.97K |
|
2686
Vital Farms
VITL
$2.11B
| $365K | ﹤0.01% |
20,781
+1,150
| +6% | +$20.2K |
|
|
GPX
2687
DELISTED
GP Strategies Corp.
GPX
| $365K | ﹤0.01% |
17,609
-519
| -3% | -$10.8K |
|
2688
Atlanta Braves Holdings Series A
BATRA
$2.92B
| $363K | ﹤0.01% |
13,474
+155
| +1% | +$4.18K |
|
|
BFX
2689
DELISTED
BowFlex Inc.
BFX
| $363K | ﹤0.01% |
39,019
+1,300
| +3% | +$12.1K |
|
2690
Radiant Logistics
RLGT
$304M
| $362K | ﹤0.01% |
56,684
-31
| -0.1% | -$198 |
|
2691
Spero Therapeutics
SPRO
$111M
| $361K | ﹤0.01% |
19,590
+1,025
| +6% | +$18.9K |
|
|
BRT
2692
BRT Apartments
BRT
$283M
| $360K | ﹤0.01% |
18,652
+745
| +4% | +$14.4K |
|
2693
GCM Grosvenor
GCMG
$682M
| $358K | ﹤0.01% |
31,063
+2,870
| +10% | +$33.1K |
|
|
ICVX
2694
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $356K | ﹤0.01% |
+12,025
| New | +$356K |
|
2695
Mesa Air Group
MESA
$55.7M
| $355K | ﹤0.01% |
46,398
+1,191
| +3% | +$9.11K |
|
2696
iShares Russell Mid-Cap Growth ETF
IWP
$20.6B
| $352K | ﹤0.01% |
3,141
-2,165
| -41% | -$243K |
|
2697
Rekor Systems
REKR
$153M
| $350K | ﹤0.01% |
30,433
+1,448
| +5% | +$16.7K |
|
|
SURF
2698
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $350K | ﹤0.01% |
46,288
+1,850
| +4% | +$14K |
|
2699
Ares Capital
ARCC
$15.7B
| $349K | ﹤0.01% |
17,153
| – | – |
|
2700
Superior Group of Companies
SGC
$197M
| $349K | ﹤0.01% |
14,965
+363
| +2% | +$8.47K |
|